Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Immunogenicity and safety of pandemic influenza A (H1N1) 2009 vaccine: systematic review and meta-analysis.

Yin JK, Khandaker G, Rashid H, Heron L, Ridda I, Booy R.

Influenza Other Respir Viruses. 2011 Sep;5(5):299-305. doi: 10.1111/j.1750-2659.2011.00229.x. Epub 2011 Mar 21. Review.

PMID:
21668694
[PubMed - indexed for MEDLINE]
2.

[Assessment of the MF59-adjuvanted pandemic influenza A/H1N1 vaccine. Systematic review of literature].

Ruiz-Aragón J, Grande Tejada AM, Márquez-Peláez S, Molina Linde JM, Yang R.

An Pediatr (Barc). 2013 Oct;79(4):208-17. doi: 10.1016/j.anpedi.2013.01.022. Epub 2013 Mar 13. Review. Spanish.

PMID:
23490433
[PubMed - indexed for MEDLINE]
Free Article
3.

Immunogenicity and safety of inactivated influenza vaccines in primed populations: a systematic literature review and meta-analysis.

Beyer WE, Nauta JJ, Palache AM, Giezeman KM, Osterhaus AD.

Vaccine. 2011 Aug 5;29(34):5785-92. doi: 10.1016/j.vaccine.2011.05.040. Epub 2011 May 30. Review.

PMID:
21624411
[PubMed - indexed for MEDLINE]
5.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic.

Broadbent AJ, Subbarao K.

Curr Opin Virol. 2011 Oct;1(4):254-62. doi: 10.1016/j.coviro.2011.08.002. Review.

PMID:
22125588
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Safety of pandemic H1N1 vaccines in children and adolescents.

Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.

Vaccine. 2011 Oct 6;29(43):7559-71. doi: 10.1016/j.vaccine.2011.08.016. Epub 2011 Aug 5. Review.

PMID:
21821086
[PubMed - indexed for MEDLINE]
7.

Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine.

Walker WT, Faust SN.

Expert Rev Vaccines. 2010 Dec;9(12):1385-98. doi: 10.1586/erv.10.141. Review.

PMID:
21105775
[PubMed - indexed for MEDLINE]
8.

Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis.

Manzoli L, Salanti G, De Vito C, Boccia A, Ioannidis JP, Villari P.

Lancet Infect Dis. 2009 Aug;9(8):482-92. doi: 10.1016/S1473-3099(09)70153-7. Review.

PMID:
19628173
[PubMed - indexed for MEDLINE]
9.

Pandemic influenza A (H1N1) 2009 vaccination in children: a UK perspective.

de Whalley PC, Pollard AJ.

J Paediatr Child Health. 2013 Mar;49(3):E183-8. doi: 10.1111/jpc.12037. Epub 2012 Dec 16. Review.

PMID:
23253033
[PubMed - indexed for MEDLINE]
10.

Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.

Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR.

Vaccine. 2013 Oct 25;31(45):5168-77. doi: 10.1016/j.vaccine.2013.08.056. Epub 2013 Sep 5. Review.

PMID:
24012574
[PubMed - indexed for MEDLINE]
11.

[Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].

Hara M, Ohfuji S, Fukushima W, Hirota Y.

Nihon Eiseigaku Zasshi. 2013;68(3):153-60. Review. Japanese.

PMID:
24077487
[PubMed - indexed for MEDLINE]
Free Article
12.

Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants.

Ahmed SS, Schur PH, MacDonald NE, Steinman L.

J Autoimmun. 2014 May;50:1-11. doi: 10.1016/j.jaut.2014.01.033. Epub 2014 Feb 19. Review.

PMID:
24559657
[PubMed - indexed for MEDLINE]
Free Article
13.

Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action.

Barker CI, Snape MD.

Lancet Infect Dis. 2014 Mar;14(3):227-38. doi: 10.1016/S1473-3099(13)70238-X. Epub 2013 Dec 19. Review.

PMID:
24360892
[PubMed - indexed for MEDLINE]
14.

Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic.

López-Macías C.

Hum Vaccin Immunother. 2012 Mar;8(3):411-4. doi: 10.4161/hv.18757. Epub 2012 Feb 14. Review.

PMID:
22330956
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events.

Marra F, Young F, Richardson K, Marra CA.

Influenza Other Respir Viruses. 2013 Jul;7(4):584-603. doi: 10.1111/irv.12000. Epub 2012 Sep 13. Review.

PMID:
22974174
[PubMed - indexed for MEDLINE]
16.

Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis.

Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, Loeb M.

BMJ. 2013 Aug 23;347:f5061. doi: 10.1136/bmj.f5061. Review.

PMID:
23974637
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Influenza vaccination in children being treated with chemotherapy for cancer.

Goossen GM, Kremer LC, van de Wetering MD.

Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006484. doi: 10.1002/14651858.CD006484.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;8:CD006484.

PMID:
19370636
[PubMed - indexed for MEDLINE]
18.

Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses.

Manzoli L, Ioannidis JP, Flacco ME, De Vito C, Villari P.

Hum Vaccin Immunother. 2012 Jul;8(7):851-62. doi: 10.4161/hv.19917. Epub 2012 Jul 1. Review.

PMID:
22777099
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Influenza vaccines: from surveillance through production to protection.

Tosh PK, Jacobson RM, Poland GA.

Mayo Clin Proc. 2010 Mar;85(3):257-73. doi: 10.4065/mcp.2009.0615. Epub 2010 Jan 29. Review.

PMID:
20118381
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Guillain-Barré syndrome after exposure to influenza virus.

Lehmann HC, Hartung HP, Kieseier BC, Hughes RA.

Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Review.

PMID:
20797646
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk